| 2026-02-03 | -28.9% | news | Seeking Alpha | NRC signals 8% TRCV growth into 2026 as go-to-market strategy gains traction |
| 2026-02-03 | -28.9% | earnings | Seeking Alpha | National Research Corporation (NRC) Q4 2025 Earnings Call Prepared Remarks Transcript |
| 2026-02-03 | -28.9% | earnings | Seeking Alpha | National Research Non-GAAP EPS of $0.16, revenue of $35.2M |
| 2026-02-03 | -28.9% | news | Seeking Alpha | National Research declares $0.16 dividend |
| 2026-02-03 | -28.9% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2025-10-28 | +17.5% | news | Seeking Alpha | NRC signals sustained momentum with $142M TRCV and enhanced dividend while strengthening management team |
| 2025-10-28 | +17.5% | earnings | Seeking Alpha | National Research Corporation (NRC) Q3 2025 Earnings Call Prepared Remarks Transcript |
| 2025-10-28 | +17.5% | news | Seeking Alpha | National Research raises dividend by 33.3% to $0.16 |
| 2024-05-07 | -15.5% | earnings | Seeking Alpha | National Research GAAP EPS of $0.27, revenue of $35.31M |
| 2024-05-07 | -15.5% | legal | SEC EDGAR | NRC 8-K: 2.02, 5.02 (SEC Filing) |
| 2025-04-09 | -12.3% | legal | SEC EDGAR | NRC 8-K: 5.02 (SEC Filing) |
| 2025-10-27 | +12.2% | earnings | Seeking Alpha | National Research Non-GAAP EPS of $0.23, revenue of $34.61M |
| 2025-10-27 | +12.2% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2024-08-06 | -11.9% | legal | SEC EDGAR | NRC 8-K: 1.01, 2.02 (SEC Filing) |
| 2026-03-09 | +10.8% | news | Business Wire | NRC Health Announces Board Authorization of $60 Million Share Repurchase Program |
| 2026-03-09 | +10.8% | news | Seeking Alpha | NRC falls after announcing $60 million share repurchase program |
| 2026-03-09 | +10.8% | news | Seeking Alpha | Top 10 healthcare stocks with highest dividend yield amid volatile markets |
| 2025-04-28 | +10.1% | legal | SEC EDGAR | NRC 8-K: 2.02, 7.01 (SEC Filing) |
| 2024-08-07 | -9.3% | earnings | Seeking Alpha | National Research GAAP EPS of $0.26, revenue of $35M |
| 2025-07-29 | -9.0% | earnings | Seeking Alpha | National Research Corporation (NRC) Q2 2025 Earnings Call Transcript |
| 2026-02-09 | -8.9% | earnings | Zacks | NRC's Q4 Earnings Down Y/Y on High Client Attrition, Stock Falls 27% |
| 2026-02-04 | -7.9% | executive | Business Wire | NRC Health Named #1 Best in KLAS Again for Healthcare Experience Management |
| 2026-02-04 | -7.9% | news | Simply Wall St. | A Look At The Fair Value Of National Research Corporation (NASDAQ:NRC) |
| 2025-01-27 | -7.5% | legal | SEC EDGAR | NRC 8-K: 2.02, 7.01 (SEC Filing) |
| 2025-03-24 | -7.1% | news | Seeking Alpha | National Research declares $0.12 dividend |
| 2021-05-05 | -6.7% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2022-05-05 | +6.0% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2022-11-03 | +5.6% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2025-07-30 | -5.2% | news | Seeking Alpha | National Research declares $0.12 dividend |
| 2024-01-02 | +5.1% | legal | SEC EDGAR | NRC 8-K: 5.02 (SEC Filing) |
| 2026-03-13 | +5.0% | news | Insider Monkey | What Makes National Research Corporation (NRC) a Good Investment Choice? |
| 2024-05-11 | -4.9% | earnings | Seeking Alpha | National Research Corporation (NRC) Q1 2024 Earnings Call Transcript |
| 2025-08-28 | -4.9% | executive | Seeking Alpha | NRC Health appoints Shane Harrison as CFO |
| 2025-08-28 | -4.9% | legal | SEC EDGAR | NRC 8-K: 5.02 and (SEC Filing) |
| 2026-03-04 | +4.7% | news | Business Wire | NRC Health Provides Business Update |
| 2026-03-04 | +4.7% | expansion | Seeking Alpha | NRC Health says total recurring contract value exceeds $152 million |
| 2025-07-28 | -4.2% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2025-02-10 | +4.2% | legal | SEC EDGAR | NRC 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-04-29 | +4.1% | earnings | Seeking Alpha | National Research GAAP EPS of $0.25, revenue of $33.55M |
| 2022-10-03 | -4.0% | legal | SEC EDGAR | NRC 8-K: 1.01 (SEC Filing) |
| 2026-04-20 | -3.9% | legal | SEC EDGAR | NRC 8-K: 5.02, 5.03 (SEC Filing) |
| 2024-11-14 | -3.6% | legal | SEC EDGAR | NRC 8-K: 5.02 (SEC Filing) |
| 2026-01-03 | +3.6% | news | Seeking Alpha | National Research: The Turnaround Is Invisible Until It Isn't |
| 2024-02-14 | +3.3% | earnings | Seeking Alpha | National Research Corporation (NRC) Q4 2023 Earnings Call Transcript |
| 2022-08-04 | -3.3% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2026-04-07 | -3.0% | news | Simply Wall St. | TSX Penny Stocks With Market Caps Over CA$100M To Consider |
| 2026-04-07 | -3.0% | expansion | Business Wire | Ann & Robert H. Lurie Children’s Hospital of Chicago Expands Partnership with NRC Health to Strengthen Consumer Insight and Online Reputation Strategy |
| 2024-02-13 | +2.7% | legal | SEC EDGAR | NRC 8-K: 2.02, 5.02 (SEC Filing) |
| 2024-10-15 | +2.5% | legal | SEC EDGAR | NRC 8-K: 5.02 (SEC Filing) |
| 2026-04-15 | +2.4% | news | Zacks | NRC Health Surges 62% in a Year: Should You Buy the Stock? |
| 2024-10-25 | +2.3% | news | Seeking Alpha | National Research declares $0.12 dividend |
| 2024-10-25 | +2.3% | earnings | Seeking Alpha | National Research GAAP EPS of $0.24, revenue of $35.8M |
| 2024-10-25 | +2.3% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2023-05-04 | +2.2% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2023-02-16 | +2.1% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2024-09-26 | +1.8% | news | Seeking Alpha | National Research goes ex dividend tomorrow |
| 2023-08-03 | -1.8% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2025-08-12 | +1.8% | news | Seeking Alpha | National Research Corporation: Hitting The Wall Unless There Is Drastic Change |
| 2023-11-08 | -1.7% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2025-04-30 | +1.3% | news | Seeking Alpha | National Research declares $0.12 dividend, up to 1M stock buybacks approved |
| 2021-05-17 | +1.1% | legal | SEC EDGAR | NRC 8-K: 5.02 and (SEC Filing) |
| 2024-03-26 | -0.9% | news | Seeking Alpha | National Research goes ex dividend tomorrow |
| 2021-11-04 | -0.8% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2024-01-17 | -0.8% | legal | SEC EDGAR | NRC 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-04-22 | +0.7% | legal | SEC EDGAR | NRC 8-K: 5.02 (SEC Filing) |
| 2025-03-04 | +0.7% | executive | Seeking Alpha | National Research Corporation appoints Trent Green as CEO |
| 2025-03-04 | +0.7% | legal | SEC EDGAR | NRC 8-K: 5.02 and (SEC Filing) |
| 2022-02-10 | +0.7% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2025-05-12 | -0.5% | legal | SEC EDGAR | NRC 8-K: 5.02 and 5.07 (SEC Filing) |
| 2026-03-19 | +0.5% | earnings | Business Wire | Piedmont Names NRC Health as a Strategic Experience Partner to Support Mission-Driven Growth |
| 2022-05-20 | +0.5% | legal | SEC EDGAR | NRC 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-05-23 | +0.3% | legal | SEC EDGAR | NRC 8-K: 5.07, 8.01 (SEC Filing) |
| 2023-06-22 | -0.3% | legal | SEC EDGAR | NRC 8-K: 1.01 (SEC Filing) |
| 2021-08-05 | -0.1% | legal | SEC EDGAR | NRC 8-K: 2.02 and (SEC Filing) |
| 2024-06-27 | +0.0% | news | Seeking Alpha | National Research goes ex dividend tomorrow |